Turning Point Brands Q2 2026 net income drops 75.2% to $3.6 million; net sales rise 22.6% to $142.9 million

Turning Point Brands Q2 2026 net sales rose 22.6% to USD 142.9 million.

Net income attributable to shareholders dropped 75.2% to USD 3.6 million; diluted EPS fell to USD 0.18 from USD 0.79.

Adjusted EBITDA slid 50% to USD 15.2 million as SG&A expenses climbed 91.1% to USD 76.9 million on sales and marketing investment.

FY 2026 Modern Oral guidance was raised to USD 330 million-350 million gross sales and USD 260 million-270 million net sales; adjusted EBITDA outlook was kept at USD 70 million-90 million.

Modern Oral gross revenue more than doubled to USD 87 million, lifting its share of total net sales by 22 percentage points to 48%.